The value of YKL-40 in ischemic heart disease patients
Introduction Atherosclerotic coronary artery disease is considered to be the most common cause of myocardial ischemia. YKL-40, a chitin-binding acute phase glycoprotein, has been found to be expressed by macrophages in atherosclerotic plaques. The YKL-40 could potentially be a new useful biomarker t...
Saved in:
Main Authors: | Doaa S.E Zaky (Author), Fatma M Mabrouk (Author), Eman R Zaki (Author), Olfat M Hendy (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2016-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Study of serum YKL-40 in children with bronchial
by: Iman A. Mohammed, et al.
Published: (2016) -
Serum YKL-40 Levels and White Matter Hyperintensities in Patients with Acute Ischemic Stroke
by: Shi G, et al.
Published: (2023) -
SERUM YKL-40 LEVELS IN CHRONIC HEART FAILURE.
by: Maria Kazakova, et al.
Published: (2014) -
YKL-40 IN SERA OF BREAST TUMOR PATIENTS
by: Maria Kazakova, et al.
Published: (2010) -
The Relationship Between Serum YKL-40 Levels on Admission and Stroke-Associated Pneumonia in Patients with Acute Ischemic Stroke
by: Shi G, et al.
Published: (2021)